Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Handshake HNS Apr 15, 2021 0.75 +1.85   
 Harmony ONE Apr 15, 2021 0.15 +1.85   
 Haven Protocol XHV Apr 15, 2021 27.15 +8.21   
 HazeCoin HAZE Apr 15, 2021 0.01 -0.02   
 Hdac HDAC Apr 15, 2021 0.08 -8.88   
 HeartBout HB Apr 15, 2021 0.01 -1.00   
 Hedera Hashgraph HBAR Apr 15, 2021 0.37 -3.26   
 Hedgecoin HEDG Apr 15, 2021 1.60 +0.80   
 HEROcoin PLAY Apr 15, 2021 0.04 +387 559.27   
 HEX HEX Apr 15, 2021 0.02 +6.07   
 High Performance Blockchain HPB Apr 15, 2021 0.56 -7.99   
 Hive HIVE Apr 15, 2021 0.61 +1.92   
 Hive HVN Apr 15, 2021 0.00 +48.53   
 Homeros HMR Apr 15, 2021 0.06 -1.05   
 HOQU HQX Apr 15, 2021 0.00 +0.89   
 Humaniq HMQ Apr 15, 2021 0.01 -0.98   
 Huobi Pool Token HPT Apr 15, 2021 0.02 +0.92   
 Huobi Token HT Apr 15, 2021 20.43 +0.47   
 Hxro HXRO Apr 15, 2021 0.53 +13.63   
 HYCON HYC Apr 15, 2021 0.00 -2.79   
 Hydro Protocol HOT Apr 15, 2021 0.02 -0.30   
 HyperCash HC Apr 15, 2021 1.98 -1.72   
 HyperDAO HDAO Apr 15, 2021 0.03 +3.53   
 Hyperion HYN Apr 15, 2021 0.02 +1.10   
 I-House Token IHT Apr 15, 2021 0.00 -1.25   
 ICON Project ICX Apr 15, 2021 2.51 -1.75   
 IDEX IDEX Apr 15, 2021 0.16 +1.44   
 iEx.ec RLC Apr 15, 2021 2.59 +0.67   
 Ignis IGNIS Apr 15, 2021 0.19 +2.43   
 IndaHash IDH Apr 15, 2021 0.01 +15.50   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Data:


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK